-
1دورية أكاديمية
المؤلفون: Bansal, Shweta, Canziani, Maria E.F., Birne, Rita, Anker, Stefan D., Bakris, George L., Filippatos, Gerasimos, Rossing, Peter, Ruilope, Luis M., Farjat, Alfredo E., Kolkhof, Peter, Lage, Andrea, Brinker, Meike, Pitt, Bertram
المساهمون: NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
مصطلحات موضوعية: cardiovascular disease, diabetes & endocrinology, diabetic nephropathy & vascular disease, risk factors, Medicine(all), SDG 3 - Good Health and Well-being
العلاقة: PURE: 87105363; PURE UUID: a6908a51-9036-424f-aadf-e5be0155c7c6; Scopus: 85188318691; PubMed: 38508632; http://hdl.handle.net/10362/167896Test; https://doi.org/10.1136/bmjopen-2023-076444Test
-
2دورية أكاديمية
المؤلفون: Dikang Pan, Julong Guo, Zhixiang Su, Wenzhuo Meng, Jingyu Wang, Jianming Guo, Yongquan Gu
مصطلحات موضوعية: Management and Treatment of Peripheral Arterial Disease, Surgery, Medicine, Health Sciences, Rhabdomyolysis and Compartment Syndromes, Chronic Kidney Disease and Dialysis Treatment, Nephrology, Nutrition, Peripheral Arterial Disease, Quartile, Cross-sectional study, Internal medicine, Logistic regression, Subgroup analysis, Angiology, Arterial disease, Odds ratio, Confidence interval, Vascular disease, Pathology
-
3دورية أكاديمية
المؤلفون: Mark Twyford, Daniel Westby, Colum Keohane, Wael Tawfick, Stewart Walsh
مصطلحات موضوعية: Cardiovascular medicine and haematology, Cardiology (incl. cardiovascular diseases), Surgery, Intermittent pneumatic compression devices, Wound Express, Chronic limb-threatening ischemia, Wound healing, Vascular Quality of Life Questionnaire, peripheral vascular disease
-
4دورية أكاديمية
مصطلحات موضوعية: Dabigatran, cardiopulmonary bypass, coagulation, idarucizumab, pharmacokinetics, 3214 Pharmacology and Pharmaceutical Sciences, 32 Biomedical and Clinical Sciences, Hematology, Science & Technology, Life Sciences & Biomedicine, Cardiac & Cardiovascular Systems, Peripheral Vascular Disease, Cardiovascular System & Cardiology, MEMBRANE-OXYGENATION, OPEN-LABEL, CHILDREN, MODEL, BIVALIRUDIN, METABOLITE, ETEXILATE, 1102 Cardiorespiratory Medicine and Haematology, 3201 Cardiovascular medicine and haematology
جغرافية الموضوع: England
وصف الملف: Print-Electronic; application/pdf
العلاقة: Perfusion; (2024). Perfusion, 2676591231226291-.; https://hdl.handle.net/2292/68082Test; 38171494 (pubmed)
-
5دورية أكاديمية
المؤلفون: Murray-Smith, H, Barker, S, Barkhof, F, Barnes, J, Brown, TM, Captur, G, R.E.Cartlidge, M, Cash, DM, Coath, W, Davis, D, Dickson, JC, Groves, J, Hughes, AD, James, SN, Keshavan, A, Keuss, SE, King-Robson, J, Lu, K, Malone, IB, Nicholas, JM, Rapala, A, Scott, CJ, Street, R, Sudre, CH, Thomas, DL, Wong, A, Wray, S, Zetterberg, H, Chaturvedi, N, Fox, NC, Crutch, SJ, Richards, M, Schott, JM
المصدر: BMC Neurology , 24 , Article 40. (2024)
مصطلحات موضوعية: Ageing, Alzheimer’s disease, Birth cohort, Cognition, Epidemiology, Genetics, Life course, Magnetic resonance imaging, Positron emission tomography, Vascular disease
وصف الملف: application/pdf
العلاقة: https://discovery.ucl.ac.uk/id/eprint/10186342/1/s12883-023-03465-3.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10186342Test/
-
6دورية أكاديمية
المؤلفون: DELL'ACQUA, Ninon, GAMBETTA, Gregory, DELZON, Sylvain, FERRER, Nathalie, LAMARQUE, Laurent, SAURIN, Nicolas, THEODORE, Pauline, DELMAS, Chloe E. L.
مصطلحات موضوعية: Dendrometer, Esca, Gas exchange, Grapevine, Plant hydraulics, Radial growth, Vascular disease, Xylem anatomy, Sciences du Vivant [q-bio]/Biologie végétale/Phytopathologie et phytopharmacie, Sciences du Vivant [q-bio]/Biologie végétale/Amélioration des plantes, Sciences du Vivant [q-bio]/Sciences agricoles/Sciences et techniques de l'agriculture
الإتاحة: https://doi.org/20.500.12278/197499Test
https://doi.org/10.1093/aob/mcad188/7464011Test
https://oskar-bordeaux.fr/handle/20.500.12278/197499Test
https://hdl.handle.net/20.500.12278/197499Test -
7دورية أكاديمية
المؤلفون: Berg, Katherine M, Bray, Janet E, Ng, Kee-Chong, Liley, Helen G, Greif, Robert, Carlson, Jestin N, Morley, Peter T, Drennan, Ian R, Smyth, Michael, Scholefield, Barnaby R, Weiner, Gary M, Cheng, Adam, Djärv, Therese, Abelairas-Gómez, Cristian, Acworth, Jason, Andersen, Lars W, Atkins, Dianne L, Berry, David C, Bhanji, Farhan, Bierens, Joost, Bittencourt Couto, Thomaz, Borra, Vere, Böttiger, Bernd W, Bradley, Richard N, Breckwoldt, Jan, Cassan, Pascal, Chang, Wei-Tien, Charlton, Nathan P, Chung, Sung Phil, Considine, Julie, Costa-Nobre, Daniela T, Couper, Keith, Dainty, Katie N, Dassanayake, Vihara, Davis, Peter G, Dawson, Jennifer A, de Almeida, Maria Fernanda, De Caen, Allan R, Deakin, Charles D, Dicker, Bridget, Douma, Matthew J, Eastwood, Kathryn, El-Naggar, Walid, Fabres, Jorge G, Fawke, Joe, Fijacko, Nino, Finn, Judith C, Flores, Gustavo E, Foglia, Elizabeth E, Folke, Fredrik, Gilfoyle, Elaine, Goolsby, Craig A, Granfeldt, Asger, Guerguerian, Anne-Marie, Guinsburg, Ruth, Hatanaka, Tetsuo, Hirsch, Karen G, Holmberg, Mathias J, Hosono, Shigeharu, Hsieh, Ming-Ju, Hsu, Cindy H, Ikeyama, Takanari, Isayama, Tetsuya, Johnson, Nicholas J, Kapadia, Vishal S, Kawakami, Mandira Daripa, Kim, Han-Suk, Kleinman, Monica E, Kloeck, David A, Kudenchuk, Peter, Kule, Amy, Kurosawa, Hiroshi, Lagina, Anthony T, Lauridsen, Kasper G, Lavonas, Eric J, Lee, Henry C, Lin, Yiqun, Lockey, Andrew S, Macneil, Finlay, Maconochie, Ian K, Madar, R John, Malta Hansen, Carolina, Masterson, Siobhan, Matsuyama, Tasuku, McKinlay, Christopher JD, Meyran, Daniel, Monnelly, Vix, Nadkarni, Vinay, Nakwa, Firdose L, Nation, Kevin J, Nehme, Ziad, Nemeth, Michael, Neumar, Robert W, Nicholson, Tonia, Nikolaou, Nikolaos, Nishiyama, Chika, Norii, Tatsuya, Nuthall, Gabrielle A, Ohshimo, Shinchiro, Olasveengen, Theresa M, Ong, Yong-Kwang Gene, Orkin, Aaron M, Parr, Michael J, Patocka, Catherine, Perkins, Gavin D, Perlman, Jeffrey M, Rabi, Yacov, Raitt, James, Ramachandran, Shalini, Ramaswamy, Viraraghavan V, Raymond, Tia T, Reis, Amelia G, Reynolds, Joshua C, Ristagno, Giuseppe, Rodriguez-Nunez, Antonio, Roehr, Charles C, Rüdiger, Mario, Sakamoto, Tetsuya, Sandroni, Claudio, Sawyer, Taylor L, Schexnayder, Steve M, Schmölzer, Georg M, Schnaubelt, Sebastian, Semeraro, Federico, Singletary, Eunice M, Skrifvars, Markus B, Smith, Christopher M, Soar, Jasmeet, Stassen, Willem, Sugiura, Takahiro, Tijssen, Janice A, Topjian, Alexis A, Trevisanuto, Daniele, Vaillancourt, Christian, Wyckoff, Myra H, Wyllie, Jonathan P, Yang, Chih-Wei, Yeung, Joyce, Zelop, Carolyn M, Zideman, David A, Nolan, Jerry P, Collaborators
مصطلحات موضوعية: Collaborators, Humans, Premature Birth, First Aid, Cardiopulmonary Resuscitation, Consensus, Adult, Child, Infant, Newborn, Emergency Medical Services, Female, Out-of-Hospital Cardiac Arrest, AHA Scientific Statements, advanced life support, cardiac arrest, pediatrics, 32 Biomedical and Clinical Sciences, 3202 Clinical Sciences, 42 Health Sciences, Pediatric, Heart Disease, Cardiovascular, Physical Injury - Accidents and Adverse Effects, Science & Technology, Life Sciences & Biomedicine, Cardiac & Cardiovascular Systems, Peripheral Vascular Disease, Cardiovascular System & Cardiology, HOSPITAL CARDIAC-ARREST
جغرافية الموضوع: United States
وصف الملف: Print-Electronic; application/pdf
العلاقة: Circulation; (2023). Circulation, 148(24), e187-e280.; https://hdl.handle.net/2292/68768Test; 37942682 (pubmed)
-
8دورية أكاديمية
المؤلفون: E. V. Gerasimova, T. V. Popkova, I. G. Kirillova, D. A. Gerasimova, E. L. Nasonov, Е. В. Герасимова, Т. В. Попкова, И. Г. Кириллова, Д. А. Герасимова, Е. Л. Насонов
المساهمون: Настоящее исследование выполнено в рамках фундаментальной темы № 1021051402790-6 «Изучение иммунопатологии, диагностики и терапии на ранних стадиях системных ревматических заболеваний».
المصدر: Rheumatology Science and Practice; Vol 62, No 1 (2024); 81-89 ; Научно-практическая ревматология; Vol 62, No 1 (2024); 81-89 ; 1995-4492 ; 1995-4484
مصطلحات موضوعية: атеросклеротическое поражение сосудов, tocilizumab, traditional risk factors, dyslipidemia, total cardiovascular risk, SCORE, atherosclerotic vascular disease, тоцилизумаб, традиционные факторы риска, дислипидемия, суммарный сердечно-сосудистый риск
وصف الملف: application/pdf
العلاقة: https://rsp.mediar-press.net/rsp/article/view/3516/2351Test; England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: Mechanisms and implications. BMJ. 2018;23(361):1036. doi:10.1136/bmj.k1036; Balsa A, Lojo-Oliveira L, Alperi-López M, García-Manrique M, Ordóñez-Cañizares C, Pérez L, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: The Spanish cohort of the COMORA study. Reumatol Clin (Engl Ed). 2019;15(2):102-108. doi:10.1016/j.reuma.2017.06.002; Насонов ЕЛ (ред.). Российские клинические рекомендации. Ревматология. М.:ГЭОТАР-Медиа;2020.; Baghdadi LR, Woodman RJ, Shanahan EM, Mangoni AA. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: A systematic review and meta-analysis. PLoS One. 2015;10(2):0117952. doi:10.1371/journal.pone.0117952; Удачкина ЕВ, Новикова ДС, Попкова ТВ, Насонов ЕЛ. Роль интерлейкина 6 в развитии атеросклероза при ревматоидном артрите. Современная ревматология. 2013;7(3):25-32. doi:10.14412/1996-7012-2013-7; Eltoft A, Arntzen KA, Wilsgaard T, Mathiesen EB, Johnsen SH. Interleukin-6 is an independent predictor of progressive atherosclerosis in the carotid artery: The Tromsø Study. Atherosclerosis. 2018;271:1-8.; Lubrano V, Gabriele M, Puntoni MR, Longo V, Pucci L. Relationship among IL-6, LDL cholesterol and lipid peroxidation. Cell Mol Biol Lett. 2015;20(2):310-322. doi:10.1515/cmble-2015-0020; Barra LJ, Pope JE, Hitchon C, Boire G, Schieir O, Lin D, et al.; CATCH group. The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis. Rheumatology (Oxford). 2017;56(5):768-776. doi:10.1093/rheumatology/kew474; Насонов ЕЛ, Попкова ТВ. Атеросклероз: перспективы противовоспалительной терапии. Терапевтический архив. 2018;90(5):4-12. doi:10.26442/terarkh20189054-12; McInnes IB, Thompson L, Giles JT, Bathon JM, Salmon JE, Beaulieu AD, et al. Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study. Ann Rheum Dis. 2015;74(4):694-702. doi:10.1136/annrheumdis-2013-204345; Castagné B, Viprey M, Martin K, Schott A-M, Cucherat M, Soubrier M. Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis. PLoS One. 2019;14(8):0220178. doi:10.1371/journal.pone.0220178; Jones G, Wallace T, McIntosh MJ, Brockwell L, Gómez-Reino JJ, Sebba A. Five-year efficacy and safety of tocilizumab monotherapy in patients with rheumatoid arthritis who were methotrexateand biologic-naive or free of methotrexate for 6 months: The AMBITION study. J Rheumatol. 2017;44(2):142-146. doi:10.3899/jrheum.160287; Насонов ЕЛ, Лила АМ. Ингибиция интерлейкина 6 при иммуновоспалительных ревматических заболеваниях: достижения, перспективы и надежды. Научно-практическая ревматология. 2017;55(6):590-599. doi:10.14412/1995-4484-2017-590-599; Комитет экспертов РКО. Национальные рекомендации по кардиоваскулярной профилактике. Кардиоваскулярная терапия и профилактика. 2011;10(6 Прил. 2.):46.; Герасимова ЕВ, Попкова ТВ, Мартынова АВ, Кириллова ИГ, Маркелова ЕИ, Семашко АС, и др. Динамика традиционных модифицируемых факторов риска, суммарного сердечно-сосудистого риска и структурных изменений сонных артерий у больных ревматоидным артритом на фоне длительной терапии ингибитором рецепторов интерлейкина-6. Научно-практическая ревматология. 2021;59(1):84-92. doi:10.47360/1995-4484-2021-84-92; Попкова ТВ, Новикова ДС, Панасюк ЕЮ, Авдеева АС, Удачкина ЕВ, Александрова ЕН, и др. Влияние тоцилизумаба на систему транспорта холестерина крови и ранние проявления атеросклероза у больных ревматоидным артритом. Терапевтический архив. 2012;84(5):9-18.; Gabay C, McInnes IB, Kavanaugh A, Tuckwell K, Klearman M, Pulley J, et al. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis. 2016;75(10):1806-1812. doi:10.1136/annrheumdis-2015-207872; Toussirot E. The Interrelations between biological and targeted synthetic agents used in inflammatory joint diseases, and obesity or body composition. Metabolites. 2020;10(3):107. doi:10.3390/metabo10030107; Choi I, Sagawa A, Lee E, Lee EB, Song YW. Tocilizumab increases body weight and serum adipokine levels in patients with rheumatoid arthritis independently of their treatment response: A retrospective cohort study. J Korean Med Sci. 2020;35(22):e55. doi:10.3346/jkms.2020.35.e155; Tournadre A, Pereira B, Dutheil F, Giraud C, Courteix D, Sapin V, et al. Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis. J Cachexia Sarcopenia Muscle. 2017;8(4):639-646. doi:10.1002/jcsm.12189; Wada E, Tanihata J, Iwamura A, Takeda S, Hayashi YK, Matsuda R. Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophin-deficient mice. Skelet Muscle. 2017;7(1):23. doi:10.1186/s13395-017-0140-z; Ando K, Takahashi F, Kato M, Kaneko N, Doi T, Ohe Y, et al. Tocilizumab, a proposed therapy for the cachexia of interleukin 6-expressing lung cancer. PLoS One. 2014;9(7):e102436. doi:10.1371/journal.pone.0102436; Genovese MC, McKay JD, Nasonov EL, Mysler EF, da Silva NA, Alecock E, et al. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis Rheum. 2008;58(10):2968-2980. doi:10.1002/art.23940; Soubrier M, Pei J, Durand F, Gullestad L, John A. Concomitant use of statins in tocilizumab-treated patients with rheumatoid arthritis: A post hoc analysis. Rheumatol Ther. 2017;4(1):133-149. doi:10.1007/s40744-016-0049-8; Hoffman E, Rahat MA, Feld J, Elias M, Rosner I, Kaly L, et al. Effects of tocilizumab, an anti-interleukin-6 receptor antibody, on serum lipid and adipokine levels in patients with rheumatoid arthritis. Int J Mol Sci. 2019;20(18):4633. doi:10.3390/ijms20184633; Schiff MH, Kremer JM, Jahreis A, Vernon E, Isaacs JD, van Vollenhoven RF. Integrated safety in tocilizumab clinical trials. Arthritis Res Ther. 2011;13:141. doi:10.1186/ar3455; IL6R Genetics Consortium Emerging Risk Factors Collaboration; Sarwar N, Butterworth AS, Freitag DF, Gregson J, Willeit P, Gorman DN, et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet. 2012; 379(9822):1205-1213. doi:10.1016/S0140-6736(11)61931-4; Navarro G, Taroumian S, Barroso N, Duan L, Furs D. Tocilizumab in rheumatoid arthritis: A meta-analysis of efficacy and selected clinical conundrums. Semin Arthritis Rheum. 2014;43(4):458-469. doi:10.1016/j.semarthrit.2013.08.001; Kitas GD, Nightingale P, Armitage J, Sattar N, Belch JJF, Symmons DP. A multicenter, randomized, placebo-controlled trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheumatol. 2019;71(9):1437-1449. doi:10.1002/art.40892; Abeles AM, Pillinge MH. Statins as antiinflammatory and immunomodulatory agents: A future in rheumatologic therapy? Arthritis Rheumatol. 2006;54(2):393-407. doi:10.1002/art.21521; Halacoglu J, Shea LA. Cardiovascular risk assessment and therapeutic implications in rheumatoid arthritis. J Cardiovasc Transl Res. 2020;13:878-90. doi:10.1007/s12265-020-09964-9; Tanaka T, Narazaki M, Ogata A, Kishimoto T. A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy. Semin Immunol. 2014;26(1):88-96. doi:10.1016/j.smim.2014.01.009; Cacciapaglia F, Anelli MG, Rinaldi A, Fornaro M, Lopalco G, Scioscia C, et al. Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment. Mediators Inflamm. 2018;2018:2453265. doi:10.1155/2018/2453265; Kim SC, Solomon DH, Rogers JR, Gale S, Klearman M, Sarsour K, et al. Cardiovascular safety of tocilizumab versus tumor necrosis factor inhibitors in patients with rheumatoid arthritis: A multi-database cohort study. Arthritis Rheumatol. 2017;69(6):1154-1164. doi:10.1002/art.40084; Ferraz-Amaro I, Hernández-Hernández MV, Tejera-Segura B, Delgado-Frías E, Macía-Díaz M, Machado JD, et al. Effect of IL-6 receptor blockade on proprotein convertase subtilisin/kexin type9 and cholesterol efflux capacity in rheumatoid arthritis patients. Horm Metab Res. 2019;51(3):200-209. doi:10.1055/a-0833-4627; Strang AC, Bisoendial RJ, Kootte RS, Schulte DM, DallingaThie GM, Levels JH, et al. Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis. Atherosclerosis. 2013;229(1):174-181. doi:10.1016/j.atherosclerosis.2013.04.031; Ruiz-Limón P, Ortega R, Arias de la Rosa I, Abalos-Aguilera MDC, Perez-Sanchez C, Jimenez-Gomez Y, et al. Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation. Transl Res. 2017;183:87-103. doi:10.1016/j.trsl.2016.12.003; Bacchiega BC, Bacchiega AB, Usnayo MJG, Bedirian R, Singh G, Pinheiro G. Interleukin 6 inhibition and coronary artery disease in a high-risk population: A prospective community-based clinical study. J Am Heart Assoc. 2017;6(3):e005038. doi:10.1161/JAHA.116.005038; Ikonomidis I, Pavlidis G, Katsimbri P, Andreadou I, Triantafyllidi H, Tsoumani M, et al. Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function. Clin Res Cardiol. 2019;108(10):1093-1101. doi:10.1007/s00392-019-01443-9; Kume K, Amano K, Yamada S, Hatta K, Ohta H, Kuwaba N. Tocilizumab monotherapy reduces arterial stiffness as effectively as An open-label randomized controlled trial. J Rheumatol. 2011;38(10):2169-2171. doi:10.3899/jrheum.110340; Chen DY, Chen YM, Hsieh TY, Hsieh CW, Lin CC, Lan JL. Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis. Arthritis Res Ther. 2015;17(1):52. doi:10.1186/s13075-015-0559-8; Rao VU, Pavlov A, Klearman M, Musselman D, Giles JT, Bathon JM, et al. An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy. Arthritis Rheumatol. 2015;67(2):372-380. doi:10.1002/art.38920; Okazaki S, Sakaguchi M, Miwa K, Furukado S, Yamagami H, Yagita Y, et al. Association of interleukin-6 with the progression of carotid atherosclerosis: A 9-year follow-up study. Stroke. 2014;45(10):2924-2929. doi:10.1161/STROKEAHA.114.005991; Puz P, Lasek-Bal A. Repeated measurements of serum concentrations of TNF-alpha, interleukin-6 and interleukin-10 in the evaluation of internal carotid artery stenosis progression. Atherosclerosis. 2017;263:97-103. doi:10.1016/j.atherosclerosis.2017.06.008; Pauli N, Puchałowicz K, Kuligowska A, Krzystolik A, Dziedziejko V, Safranow K, et al. Associations between IL-6 and echoparameters in patients with early onset coronary artery disease. Diagnostics (Basel). 2019;9(4):189. doi:10.3390/diagnostics9040189; Zhang J, Xie F, Yun H, Chen L, Muntner P, Levitan EB, et al. Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis. Ann Rheum Dis. 2016;75(10):1813-1818. doi:10.1136/annrheumdis-2015-207870; Grange S, Schmitt C, Ganeshalingam K, Choy EH. Tocilizumab did not significantly increase serum cholesterol levels in healthy subjects. Rheumatology (Oxford). 2014;53:95-96. doi:10.1093/rheumatology/keu101.023; Specker C, Aringer M, Burmester GR, Killy B, Hofmann MW, Kellner H, et al. The safety and effectiveness of tocilizumab in elderly patients with rheumatoid arthritis and in patients with comorbidities associated with age. Clin Exp Rheumatol. 2022;40(9):1657-1665. doi:10.55563/clinexprheumatol/f7ff6q; Specker C, Alberding A, Aringer M, Burmester GR, Flacke JP, Hofmann MW, et al. ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritis. Clin Exp Rheumatol. 2021;39(2):319-328. doi:10.55563/clinexprheumatol/3qdgi1; Jones G, Panova E. New insights and long-term safety of tocilizumab in rheumatoid arthritis. Ther Adv Musculoskelet Dis. 2018;10(10):195-199. doi:10.1177/1759720X18798462; Gale S, Trinh H, Tuckwell K, Collinson N, Stone JH, Sarsour K, et al. Adverse events in giant cell arteritis and rheumatoid arthritis patient populations: Analyses of tocilizumab clinical trials and claims data. Rheumatol Ther. 2019;6(1):77-88. doi:10.1007/s40744-019-0139-5; https://rsp.mediar-press.net/rsp/article/view/3516Test
الإتاحة: https://doi.org/10.47360/1995-4484-2024-81-89Test
https://doi.org/10.1136/bmj.k1036Test
https://doi.org/10.1016/j.reuma.2017.06.002Test
https://doi.org/10.1371/journal.pone.0117952Test
https://doi.org/10.14412/1996-7012-2013-7Test
https://doi.org/10.1515/cmble-2015-0020Test
https://doi.org/10.1093/rheumatology/kew474Test
https://doi.org/10.26442/terarkh20189054-12Test
https://doi.org/10.1136/annrheumdis-2013-204345Test
https://doi.org/10.1371/journal.pone.0220178Test -
9دورية أكاديمية
المؤلفون: Salau, Ayodeji Olalekan, Assegie, Tsehay Admassu, Markus, Elisha Didam, Eneh, Joy Nnenna, Ozue, ThankGod Izuchukwu
المصدر: International Journal of Electrical and Computer Engineering (IJECE); Vol 14, No 2: April 2024; 1809-1815 ; 2722-2578 ; 2088-8708 ; 10.11591/ijece.v14i2
مصطلحات موضوعية: Automated decision making, Cardio vascular disease, Data analytics, Heart disease risk, Predictive analytics
وصف الملف: application/pdf
العلاقة: https://ijece.iaescore.com/index.php/IJECE/article/view/32102/17317Test; https://ijece.iaescore.com/index.php/IJECE/article/view/32102Test
الإتاحة: https://doi.org/10.11591/ijece.v14i2.pp1809-1815Test
https://doi.org/10.11591/ijece.v14i2Test
https://ijece.iaescore.com/index.php/IJECE/article/view/32102Test -
10دورية أكاديمية
المؤلفون: Patel, Isha, Yadav, Arti, Swaroop, Suchit
المصدر: Journal of Ecophysiology and Occupational Health; Online First ; 0974-0805 ; 0972-4397
مصطلحات موضوعية: Chronic Vascular Disease (CVD), NAFLD, Obesity
وصف الملف: application/pdf